Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse

Posttransplantation, glasdegib maintenance therapy in patients at high risk for relapse did not meaningfully reduce relapse incidence. Use of glasdegib in the posttransplantation setting was complicated by adverse events requiring drug holds and occasional discontinuation.

Na minha lista:
Bibliografiske detaljer
Udgivet i:Blood Adv
Main Authors: Kent, Andrew, Vasu, Sumithira, Schatz, Derek, Monson, Natalie, Devine, Steven, Smith, Clayton, Gutman, Jonathan A., Pollyea, Daniel A.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Hematology 2020
Fag:
Stimulus Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7362348/
https://ncbi.nlm.nih.gov/pubmed/32634235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001991
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker